Shares of VentriPoint Diagnostics Ltd. (CVE:VPT – Get Free Report) rose 29% on Friday . The company traded as high as C$0.20 and last traded at C$0.20. Approximately 414,232 shares changed hands during trading, an increase of 48% from the average daily volume of 280,587 shares. The stock had previously closed at C$0.16.
VentriPoint Diagnostics Price Performance
The company has a quick ratio of 6.67, a current ratio of 0.28 and a debt-to-equity ratio of -58.56. The stock has a market cap of C$27.57 million, a price-to-earnings ratio of -5.25 and a beta of 0.39. The stock has a fifty day moving average of C$0.10 and a two-hundred day moving average of C$0.13.
VentriPoint Diagnostics Company Profile
Ventripoint Diagnostics Ltd., a medical device company, engages in the development and commercialization of diagnostic tools that monitor patients with heart disease worldwide. It offers Ventripoint Medical System (VMS), a medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient’s heart chambers.
Further Reading
- Five stocks we like better than VentriPoint Diagnostics
- 3 Warren Buffett Stocks to Buy Now
- These 4 Tech ETFs Just Hit 50-Day Lows—Time to Buy?
- The Most Important Warren Buffett Stock for Investors: His Own
- 3 Stocks to Buy While Others Stay on the Sidelines
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- MarketBeat Week in Review – 03/03 – 03/07
Receive News & Ratings for VentriPoint Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VentriPoint Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.
